Nektar Therapeutics
NKTR
#4161
Rank
NZ$4.92 B
Marketcap
NZ$166.05
Share price
-2.18%
Change (1 day)
947.36%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$7.17

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$7.16. In 2024 the company made an earnings per share (EPS) of NZ-$5.92 an increase over its 2023 EPS that were of NZ-$37.05.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.1721.04%
2024NZ-$5.92-84.02%
2023NZ-$37.05-25.89%
2022NZ-$49.99-31.12%
2021NZ-$72.5714.86%
2020NZ-$63.18-1.19%
2019NZ-$63.94-163.96%
2018NZ$99.97-725.4%
2017NZ-$15.99-42.73%
2016NZ-$27.9183.33%
2015NZ-$15.2239.53%
2014NZ-$10.91-69.29%
2013NZ-$35.52-6.67%
2012NZ-$38.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.84-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.30-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.24-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.13-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.37-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.03-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.50-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland